北陆药业：为全资子公司陆芝葆药业提供不超过4亿元担保

Group 1 - Company announced a guarantee of up to 400 million RMB for its wholly-owned subsidiary, Luzhibao Pharmaceutical, to support the construction of a production project for traditional Chinese medicine and high-end pharmaceutical formulations [1] - The board of directors approved the guarantee at the fifth meeting of the ninth board session held on October 27, 2025, with a guarantee period not exceeding ten years [1] - As of the announcement date, the total amount of guarantees provided by the company to its subsidiaries is not more than 890 million RMB, accounting for no more than 53.37% of the company's audited net assets for 2024 [1] Group 2 - The company's revenue composition for the year 2024 indicates that 98.88% comes from pharmaceutical production, while other business income accounts for 1.12% [1] - The current market capitalization of the company is 4.8 billion RMB [2]